Navigation Links
The John Theurer Cancer Center to host Seventh Annual Neuro-Oncology Symposium
Date:5/9/2011

HACKENSACK, N.J. (May 9, 2011) The John Theurer Cancer Center at Hackensack University Medical Center will host the Seventh Annual Neuro-Oncology Symposium on Friday, May 20 from 7:30am - 1:00pm. This continuing medical education (CME) conference will present the latest neuro-oncology trends by leaders in the field.

"For the seventh consecutive year, we are able to bring together leaders in neuro-oncology to provide insights on the latest advancements in the neuro-oncology field," said Viswanathan Rajaraman, M.D., Co-Chief of Neuro-Oncology at the John Theurer Cancer Center. "We are proud to bring together a group of highly esteemed oncologists to our new comprehensive cancer center to discuss the latest trends in our field."

Topics to be discussed at the Seventh Annual Neuro-Oncology Symposium: Controversies in Neuro-Oncology and Para Neoplastic Syndromes Affecting the CNS include controversies in radiosurgery and whole brain radiotherapy in metastatic brain tumors, management of para neoplastic syndrome, management of low grade gliomas, and identifying pitfalls in neuro-oncology imaging.

"The John Theurer Cancer Center is committed to helping our staff and the tri-state area neuro-oncology medical community stay up-to -date with the latest medical advancements through educational programs," said Mark Pascal, M.D., Co- Chief, Neuro-Oncology, John Theurer Cancer Center.

The program will feature neuro-oncology experts from world-renowned institutions such as Memorial Sloan-Kettering Cancer Center, Roswell Park Cancer Institute and University of Virginia Health System. Featured speakers include:

  • Jerome Posner, M.D., Memorial Sloan-Kettering Cancer Center, New York, NY
  • Dheerendra Prasad, M.D., Roswell Park Cancer Institute, Buffalo, NY
  • David Schiff, M.D., University of Virginia Health System, Charlottesville, VA
  • Andrei Holodny, M.D., Memorial Sloan-Kettering Cancer Center, New York, NY

"It is part of our mission at the John Theurer Cancer Center to promote research and innovation through education," said Andrew L. Pecora, M.D., C.P.E., F.A.C.P., Chief Innovations Officer and Professor and Vice President of Cancer Services at the John Theurer Cancer Center. "The Neuro-Oncology Symposium is just one example of the superior continuing medical education programs we offer throughout the year."

This program is open to the public, but is designed for neurologists, neurosurgeons, medical oncologists, radiation oncologists, internists, primary care physicians, neuropsychologists, other physicians and healthcare providers. Hackensack University Medical Center designates this educational activity for a maximum of 4.0 AMA PRA Category 1 Credit(s). The program will be held at the John Theurer Cancer Center at Hackensack University Medical Center, 92 Second Street, Hackensack, NJ in the #2 conference room.

This event is complimentary, however registration is required. To register, please contact Maryann V. Lederhilger at (551) 996-1162 or mlederhilger@humed.com. For updates and additional information, please visit jtcancercenter.org/neurooncologyCME.


'/>"/>

Contact: Jaymie DeGaetano
jaymie.degaetano@widmeyer.com
646-213-7243
John Theurer Cancer Center
Source:Eurekalert

Related medicine news :

1. John Theurer Cancer Center first in New Jersey to offer complete capabilities of Provenge
2. The MMRF and John Theurer Cancer Center to host patient symposium
3. John Theurer Cancer Center orthopedic oncologist shares new limb sparing surgical techniques
4. John Theurer Cancer Center to host Eighth Annual Northern New Jersey Breast Cancer Conference
5. Oncology basic research director at John Theurer Cancer Center continues transplantation research
6. John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers
7. The John Theurer Cancer Center to unveil 40 presentations at the 52nd ASH Annual Meeting
8. John Theurer Cancer Center to present innovative research at 2 surgical meetings
9. John Theurer Cancer Center first cancer center in N.J. to acquire new radiotherapy system
10. John Theurer Cancer Center and LLS host panel discussion with leading hematologists
11. The John Theurer Cancer Center recognizes medical physics team for safety track record
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... June 28, 2017 , ... ... servicing communities throughout the greater Cincinnati metropolitan area, is teaming up with the ... for families with children receiving treatment in nearby hospitals. , Ronald McDonald House ...
(Date:6/27/2017)... ... 2017 , ... Salucro, the cloud-based payment platform that has ... and provider groups, has announced that it will now offer Parasail’s payment plans ... San Francisco health-finance startup that has launched a series of tech-based products that ...
(Date:6/27/2017)... Bradley, Illinois (PRWEB) , ... June 27, 2017 , ... ... Ill. were featured in a video designed to encourage lawmakers to protect ... and National Center for Assisted Living (AHCA/NCAL), highlights the story of Chuck and Cathy ...
(Date:6/27/2017)... Monroe, CT (PRWEB) , ... June 27, 2017 , ... ... announce the recent renovation of his practice, Advanced Periodontics and Dental Implant Center of ... and increased the administrative and waiting areas. The renovations are intended to improve patient ...
(Date:6/27/2017)... , ... June 27, 2017 , ... Children’s National Health ... Hospitals rankings, with its Neonatology program ranking #1 out of more than 1500 ... named to the coveted Honor Roll, a distinction given to the top performing children’s ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... June 7, 2017  Novavax, Inc., (Nasdaq: NVAX ... Phase 2 trials of its RSV F protein recombinant nanoparticle ... age have been published in the journal Vaccine ... shared in prior scientific conferences). The Company previously announced ... Novavax is developing the RSV F Vaccine with the goal ...
(Date:6/2/2017)... -- NxStage Medical, Inc. (Nasdaq:  NXTM), a leading medical technology company focused ... positive biochemical outcomes related to more frequent hemodialysis with ... be presented at the ERA-EDTA Congress being held June ... The research was conducted by the ... Europe (KIHDNEy) Cohort team with ...
(Date:5/29/2017)... AVIV, Israel, May 29, 2017  Cellect Biotechnology Ltd. ... innovative technology which enables the functional selection of stem ... results for the first quarter ended March 31 st ... with our accomplishments in the first quarter of 2017," ... first quarter, we announced the treatment of the first ...
Breaking Medicine Technology: